The Leader in Preventive Medicine in Asia
U-GEN strives to become a leader in the fields of genetic testing, early tumor screening, major chronic diseases and other preventive medicine for Asian and global Chinese population.
Caring of People, Life, and Health
With human life-oriented, U-GEN is a global molecular diagnostic company dedicated to the development, manufacture, sales and marketing of molecular diagnostic kits, instruments, as well as providing the services to end-users directly through reference labs in Beijing, Changsha, Xiamen, and Hong Kong. We integrate the state-of-the-art technology and resources from upstream towards downstream of the IVD industry to develop the serious of products for diseases that are the biggest threats to life, especially for the Chinese population.
Multiple Nucleic Acid Testing
Expertise in HLA testing kits with the Class III medical device registration certificate of HLA high-resolution testing kit, which is the only one issued by NMPA in China. 
Tumor Early Screening
Multiplex Immunoassay by EMMB
Our Core Competence
U-GEN combines the innovative experience and R&D energy from the United States, China, Hong Kong, and Taiwan, implement semiconductor technology into the product development to quickly establish a full range of nucleic acid detection kits and early cancer screening kits of various chronic diseases, provide services for needed people, as well as expanding the market worldwide.
M&A Integration Capacity
Regulatory Capability
Professional Management
Advanced Technology Platforms
U-GEN leverages the most advanced IVD industry technology and methodology in conjunction with our proprietary platforms to develop diagnostic kits, automated equipment, and provide personalized diagnostic services for high demands markets in China and the world.
Multiple Nucleic Acid Testing
Tumor Early Screening
Multiplex Immunoassay by EMMB
Precision Medicine Service
We have successfully established reference labs in Beijing, Changsha, Xiamen, and Hong Kong for personalized and comprehensive precision medical services. Since 2015, the service has been provided at more than 83 Class III-A hospitals, and 48 universities, medical institutions and pharma companies totally, and across 15 provinces in China.
Group Members
